企業プロフィール
Fulgent Genetics, Inc. 株価・ニュース・カタリスト
- ティッカー:
- FLGT
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
18.66 USD (+0.54%)
終値
最終更新: 2026年8月17日
531M USD
時価総額
株価変動の要因
As of Aug 17, 2026, FLGT closed up 0.54% at $18.66. No new same-company headline was identified in the current news window.
企業概要
Precision Medicine Business
Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio. The company aims to combine diagnostic capabilities with drug development to become an integrated precision-medicine organization.
Laboratory Services
Fulgent provides technical laboratory testing and physician interpretation services. Its operations include genetic and specialty diagnostic capabilities serving healthcare providers, institutions and other customers.
Oncology Therapeutics
The therapeutic business uses nanoencapsulation and targeted-delivery technology to improve the pharmacokinetics and therapeutic window of cancer drugs. Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.
今後のカタリスト
- Phase 2 FID-007 data in a rapid oral presentation at the 2026 ASCO Annual Meeting.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。